Researchers at the University of Colorado Anschutz Medical Campus are part of an international team that has discovered a molecular signature that plays a pivotal role in sustaining the activation of immune cells in chronic neurological diseases, including progressive multiple sclerosis (MS).
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Apple cider vinegar (ACV) isn’t just for salad dressings anymore. Small but highly publicized studies combined with the powerful sway of personal testimonials on social media have weight-loss and gut-health seekers drinking the acidic cooking […]
ENGLEWOOD, Colo., July 12, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]
Currently, there are no disease modifying therapies for Parkinson’s disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is […]
Copyright © 2026 Biotech Networks
